Literature DB >> 9098464

A murine model of adenomyosis: the effects of hyperprolactinemia induced by fluoxetine hydrochloride, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats.

C Fiçicioğlu1, H I Tekin, P F Arioğlu, I Okar.   

Abstract

OBJECTIVE: The aim of this study was to investigate whether fluoxetine given to castrated and noncastrated rats caused hyperprolactinemia and its effects with respect to adenomyosis.
DESIGN: Fluoxetine, a serotonin reuptake inhibitor, was given to Wistar Albino rats for 98 days to produce hyperprolactinemia. The drug was given to two groups consisting of castrated and noncastrated rats and compared to two groups of castrated and noncastrated controls. Prolactin levels were measured and the uteri of the rats were removed for histopathological analysis at the end of 98 days.
SETTING: Marmara University School of Medicine, Department of Histology and Embryology, Zeynep Kamil Women and Children's Hospital. MAIN OUTCOME MEASURES: Serum prolactin levels, uterine histopathology.
RESULTS: The prolactin levels of castrated and noncastrated groups treated with fluoxetine were statistically significantly higher when compared to their respective control groups. Histological studies revealed 11 cases of adenomyosis, all within the noncastrated group receiving fluoxetine.
CONCLUSION: It was suggested that high serum prolactin levels cause degeneration of myometrial cells in the presence of ovarian steroids that results in a myometrial invasion by endometrial stroma. This invasion eventually progresses to adenomyosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9098464

Source DB:  PubMed          Journal:  Acta Eur Fertil        ISSN: 0587-2421


  5 in total

1.  The possible role of fluoxetine in adenomyosis: an animal experiment with clinical correlations.

Authors:  Parama Sengupta; Abhishek Sharma; Gautameswar Mazumdar; Indranil Banerjee; Santanu K Tripathi; Chiranjib Bagchi; Nina Das
Journal:  J Clin Diagn Res       Date:  2013-07-01

2.  Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy.

Authors:  F A Taran; E A Stewart; S Brucker
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

3.  Understanding adenomyosis: a case control study.

Authors:  F Andrei Taran; Amy L Weaver; Charles C Coddington; Elizabeth A Stewart
Journal:  Fertil Steril       Date:  2009-07-30       Impact factor: 7.329

4.  Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence.

Authors:  Bo Zhu; Yumei Chen; Xiaolu Shen; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2016-10-10       Impact factor: 5.211

Review 5.  Unveiling the Pathogenesis of Adenomyosis through Animal Models.

Authors:  Xi Wang; Giuseppe Benagiano; Xishi Liu; Sun-Wei Guo
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.